PubMed Health⌕ Search

PubMed · 3435397

Why should senescence evolve? An answer based on a simple demographic model.

Abstract

The demographic model of senescence described here provides an answer to the question, "Why should senescence evolve?" Most generally stated, the answer is that senescence should be expected to evolve if its negative effect on the rate of natural increase of a nonsenescent population is sufficiently offset by the early appearance of an advantageous characteristic. This is a nonadaptive point of view in the sense discussed by Kirkwood (1985) and by Kirkwood and Cremer (1982). It corresponds more closely to Medawar's (1952) position than to Weisman's (1889). The demographically based model in which senescence is represented by sudden death supplies an explanation which is simple and credible for the evolution of senescence. It supports the following specific conclusions: 1. The introduction of sudden death (case 2) in a nonsenescent population otherwise subject only to randomly occurring death (case 1) is, by itself, disadvantageous from the standpoint of natural selection. 2. However the population may enjoy a net selective advantage if the disadvantage of sudden-death senescence is compensated by an appropriate improvement early in its life history, e.g., by a reduction in its presenescent death rate. 3. In the most extreme example possible, in which the presenescent death rate is zero and the survival curve is rectangular (case 3), the early improvement is associated with an increase in the degree of sensescence of the population, in its mean longevity, and in its average age at death. Thus natural selection can simultaneously favor both senescence and longevity. 4. Among populations in which the age of sudden death is balanced against the presenescent death rate in such a way that mean longevity is held constant (case 4), sudden-death senescence provides selective advantage relative to a nonsenescent population (case 1). Up to the point at which the survival curve becomes rectangular, the earlier the age at which sudden-death occurs, the greater the selective advantage. Similar conclusions were reached earlier with respect to forms of senescence which take effect more gradually than the sudden-death mechanism postulated here. 5. Populations in which the age of sudden death is balanced against the presenescent death rate in such a way that the average age at death is held constant (case 5) are selectively neutral with respect to a nonsenescent population (case 1). Thus a reduction in mortality at a nearly age can compensate for the sudden death of the whole population at an advanced age because so few individuals in the nonsenescent population survive to reproduce when old.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H R Hirsch. 1987. Why should senescence evolve? An answer based on a simple demographic model.. https://doi.org/10.1007/978-1-4613-1939-9_5

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

An open benchmark and language models for AI in aging biology.

Over the past two decades, human aging has been characterized across DNA methylation, transcriptomic, proteomic, and clinical modalities, yet no benchmark evaluates whether AI systems can interpret these heterogeneous data types in the context of aging biology. We introduce LongevityBench, an open suite of 17 tasks spanning five biodata domains, and use it to assess 18 frontier AI systems from six developer teams. Despite recent advances in AI, no single model dominates all tasks, with omics-based age prediction being the hardest task regardless of scale. To test whether these gaps can be closed without frontier-scale resources, we fine-tuned a family of five multitask Longevity-LLMs on domain-specific aging data. The compact (0.6B-9B parameters) Longevity-LLMs matched or exceeded far larger frontier systems on LongevityBench, showing that general-purpose language models can be adapted to structured-omics tasks. We publicly release the benchmark, models, and Longevity Claw, an agentic research interface for aging researchers.

Aging↗

Association between sirtuin 1 and markers of oxidative stress in master athletes.

BACKGROUND: Lifelong training in master athletes confers protective effects, promoting higher sirtuin levels and enhanced antioxidant capacity. Although Sirtuin 1 (SIRT1) is well studied, no previous study has examined the relationship between circulating SIRT1 levels and antioxidant defense variables in master athletes. PURPOSE: To compare and analyze the relationships between circulating levels of SIRT1 and variables related to antioxidant defense in master athletes (MA) and untrained middle-aged individuals (UMA). METHODS: Male MA (n&#x2009;=&#x2009;42; 51.62&#x2009;&#xb1;&#x2009;7.33 years; &#x2265;10 years of training and competition in running) and UMA (n&#x2009;=&#x2009;15; 47.73&#x2009;&#xb1;&#x2009;8.52 years) were evaluated. Venous blood samples were collected for biochemical analyses of SIRT1, antioxidant enzymes, TBARS and F2-isoprostanes, 8-OHdG, and redox balance indexes. RESULTS: MA showed higher levels of SIRT1 (18.22&#x2009;&#xb1;&#x2009;4.53 vs. 6.08&#x2009;&#xb1;&#x2009;2.11 ng/mL; p&#x2009;<&#x2009;0.0001), as well as of SOD, CAT, and GSH (p&#x2009;<&#x2009;0.001), indicating a more favorable antioxidant profile. After adjustment for body fat percentage, differences in SOD, CAT, GSH and TBARS, remained significant. SIRT1 was positively correlated with SOD (r&#x2009;=&#x2009;0.279; p&#x2009;=&#x2009;0.031), CAT (r&#x2009;=&#x2009;0.485; p&#x2009;<&#x2009;0.001), GSH (r&#x2009;=&#x2009;0.476; p&#x2009;<&#x2009;0.001) and CAT/8-OHdG (r&#x2009;=&#x2009;0.430; p&#x2009;=&#x2009;0.032), and negatively correlated with TBARS (r&#x2009;=&#x2009;-&#x2009;0.518; p&#x2009;<&#x2009;0.001). CONCLUSION: Master athletes exhibited higher circulating SIRT1 concentrations and a more favorable systemic redox profile than untrained individuals, with SIRT1 being associated with markers of antioxidant defense, lipid peroxidation, and redox balance.

Aging↗

Decoding SUMOylation as a metabolic stress sensor in aging and age-related disorders: Mechanisms, tissue specificity and therapeutic potential.

SUMOylation is a reversible post-translational modification increasingly recognized for its role in coordinating cellular responses to metabolic stress during aging. Emerging evidence indicates that it functions beyond a conventional modification, representing an adaptive stress&#x2011;responsive regulatory network that integrates metabolic, oxidative, inflammatory, and proteotoxic signals. Rather than acting on isolated pathways, this network finely tunes mitochondrial function, proteostasis, genome maintenance, immune balance, and epigenetic regulation. Accumulating evidence indicates that SUMO-dependent regulation exhibits remarkable tissue specificity, supporting mitochondrial adaptation and contractile integrity in skeletal muscle, shaping lipid and glucose metabolism in the liver, modulating proteotoxic stress and neuronal resilience in the brain, and contributing to immune cell differentiation and chronic low-grade inflammation during aging. In this review, we summarize current mechanistic insights into SUMO signaling across aging-relevant tissues, with particular emphasis on its functional interplay with other post-translational modifications, including ubiquitination and acetylation. We discuss how SUMOylation operates as a shared regulatory layer while enabling context-dependent outcomes that underlie diverse aging phenotypes and age-related disorders. Finally, we evaluate emerging translational approaches-ranging from pharmacological modulation of SUMO enzymes to lifestyle interventions such as caloric restriction and exercise-that highlight both the opportunities and challenges of targeting SUMO-regulated stress responses in aging. Together, this synthesis provides a framework for understanding how SUMOylation links metabolic stress to tissue-specific aging trajectories and therapeutic potential.

Aging↗